ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Biogen to Acquire Nightstar Therapeutics americanpharmaceuticalreview
March 06, 2019Biogen has entered into an agreement to acquire Nightstar Therapeutics, a clinical-stage gene therapy company based in London, United Kingdom, which is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders.
Pharma Sources Insight July 2025
